Week 8 Flashcards

1
Q

4 endotypes of COPD

A
  1. eosinophilic
  2. alpha 1 anti trypsin
  3. persistent bacterial colonisation
  4. persistent systematic inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 COPD phenotypes

A
  1. frequent exacerbations
  2. persistent breathlessness
  3. chronic bronchitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 T1RF signs

A

pursed lips
accessory muscles
wheeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 T2RF signs

A

flapping tremor
increased JVP
warm peripheries
cyanosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 treatments for pneumothorax

A
  1. aspiration
  2. intercostal drain
  3. VAT
    talc pleurodises
    pleural abrasion
    staple blebs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 pleural effusion examination signs

A

clubbing
ascites
lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 features of parapneumoic effusion

A
  1. LDH over 1000
  2. Glucose less than 2.2
  3. ph less than 7.2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 management of pleural infection

A

antibiotics
fibrinolytic
drain
surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

5 clinical signs of pleural effusion

A
  1. decreased chest expansion
  2. decreased tactile fremitis
  3. quiet breath
  4. rub
  5. stony dull percussion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

OSA defintion

A

recurrent partial or complete airflow obstruction during sleep, intermittent hypoxia and sleep fragmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

measure for OSA

A

apnoea hypoxia index
ap+hypop / total time asleep

normal 0-4
moderate 15-29

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

OSA symtoms

A
excessive daytime sleepiness with 2 +:
choking
decreased concentration 
recurrent awaking 
fatigue 
unrefreshing sleep
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

apnoea

A

decreased airflow of over 90% for at least 10 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hypopnea

A

dressed airflow of over 30% for at least 10 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pathophysiology of OSA

A

pharyngeal narrowing
negative thoracic pressure
increases BP
decreases sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

epworth sleepiness score

A

0 to 10 = normal range of sleepiness in healthy adults.
11 to 14 = mild sleepiness.
15 to 17 = moderate sleepiness.
18 to 24 = severe sleepiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2 quizzes in OSA

A

stop bang

berlin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

oxygen desaturation index

A

no of times per hour that spo2 goes less than 4% from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

compliance in CPAP

A

over 4 hours for over 70 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is wheeze

A

narrowing

allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is stridor

A

whistling inspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

4 histological changes in asthma

A
  1. subepithalial fibrosis
  2. smooth muscle hypertrophy
  3. thick BM
  4. mast cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

bronchial hyper responsiveness

A

drop of over 20% FEV1 by less than 8mg/ml of histamine or mannitol

24
Q

reversible airflow obstruction

A

over 15% improvement in FEV1 after 5mg nebulised salbutamol

25
4 triggers of extrinsic allergic alveolitis
moulds humidifiers lung organic dust pigeon fanciers lung
26
in EEA which type of hypersensitivity acute
3
27
in EEA which type of hypersensitivity subacute
4
28
4 clinical consequences of EEA
septa thickening loss of O2 with normal CO2 airspace shadowing T1RF
29
management of EEA
1. avoid trigger 2. corticosteroids 3. oxygen
30
4 lung cancer risks
1. smoking 2. HPV 3. radiation 4. polymorphisms in p450
31
2 lung cancers in smoking
small cell and squamous cell
32
2 consequences of a central tumour
hemoptisis | bronchial obstruction
33
1 consequences of a peripheral tumour
pain
34
3 consequences of a tumour in mediastinum
SVC obstruction and increased JVP recurrent laryngeal phrenic nerve paralysis
35
3 non metatsic effects of lung cancer
ACTH - cuhsings ADH - SIADH PTH related peptide - hypercalcemia
36
4 appearance of small cell
- oval to spindle shaped - inconspicuous nuclei - scant cytoplasm - nuclear moulding
37
who gets adenocarcinoma and where is it
in periphery | non smoking females
38
4 appearance of adenocarcinoma
glandular muslin production solid papillary
39
squamous cell carcinoma where
major bronchi
40
3 appearance of squamous cell carcinoma
cavitation intracellular bridges keratinisation
41
diagnose of large cell carcinoma
diagnosis of exclusion | sheets of malignant undifferentiated cells
42
6 other lung tumours
``` carcinoid mesenchymal salivary gland germ cell lymphatic ```
43
non small cell lunger cancer med
EML 4 ALK
44
what are 5 sarcoidosis symptoms
``` fever night swetas weight loss hemoptysis iritis cough chest apin ```
45
3 physical findings of sarcoid
nodules on skin cardiac rub non specific neurological
46
4 stages of sarcoid
1. bilateral hilar lympahdenopathy no infiltration 2. bel with infilled 3. infiltration alone 4. fibrotic bands, bull, hilarious retraction
47
non nectrosing granulomatous
sarcoidosis
48
2 treatment of sarcoid
NSAIDs | steroids
49
4 histological of sarcoid
mastoid body cytokeritin calcification nuclei with giant cell
50
idiopathic pulmonary fibrosis 6 features
``` breathlessness clubbing periperal linterstital pattern sub pleural honeycombing clubbing bibasalr crackles ```
51
5 clinical presentation of IPF
``` bretahless hacking dry cough featigue weight loss clubbing ```
52
4 causes of non IPF
CTD cocaine sarcoid genetic
53
2 diagnose of IPF
HRCT | VATS
54
treatment of IPF
pirfenidone
55
fibroblastic foci spatial heterogeneity chicken wire
UIP